User profiles for Raph L. Hamers
Raph HamersUniversity of Oxford Verified email at oucru.org Cited by 9116 |
[HTML][HTML] Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global …
Background The emergence and spread of high levels of HIV-1 drug resistance in resource-limited
settings where combination antiretroviral treatment has been scaled up could …
settings where combination antiretroviral treatment has been scaled up could …
[HTML][HTML] Clinical characteristics and mortality associated with COVID-19 in Jakarta, Indonesia: A hospital-based retrospective cohort study
…, G Thwaites, JK Baird, RL Hamers - The Lancet Regional …, 2021 - thelancet.com
Background Data on COVID-19-related mortality and associated factors from low-resource
settings are scarce. This study examined clinical characteristics and factors associated with in-…
settings are scarce. This study examined clinical characteristics and factors associated with in-…
HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study
RL Hamers, CL Wallis, C Kityo, M Siwale… - The Lancet infectious …, 2011 - thelancet.com
Background There are few data on the epidemiology of primary HIV-1 drug resistance after
the roll-out of antiretroviral treatment (ART) in sub-Saharan Africa. We aimed to assess the …
the roll-out of antiretroviral treatment (ART) in sub-Saharan Africa. We aimed to assess the …
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
Background Global genetic diversity of HIV-1 is a major challenge to the development of HIV
vaccines. We aimed to estimate the regional and global distribution of HIV-1 subtypes and …
vaccines. We aimed to estimate the regional and global distribution of HIV-1 subtypes and …
[HTML][HTML] Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient-and …
Background Regional and subtype-specific mutational patterns of HIV-1 transmitted drug
resistance (TDR) are essential for informing first-line antiretroviral (ARV) therapy guidelines …
resistance (TDR) are essential for informing first-line antiretroviral (ARV) therapy guidelines …
[HTML][HTML] Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study
Background Antiretroviral therapy (ART) is crucial for controlling HIV-1 infection through
wide-scale treatment as prevention and pre-exposure prophylaxis (PrEP). Potent tenofovir …
wide-scale treatment as prevention and pre-exposure prophylaxis (PrEP). Potent tenofovir …
[HTML][HTML] Adjunctive dexamethasone for tuberculous meningitis in HIV-positive adults
…, NTT Thuong, E Kestelyn, RL Hamers… - … England Journal of …, 2023 - Mass Medical Soc
Background Adjunctive glucocorticoids are widely used to treat human immunodeficiency
virus (HIV)–associated tuberculous meningitis despite limited data supporting their safety and …
virus (HIV)–associated tuberculous meningitis despite limited data supporting their safety and …
Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a …
RL Hamers, R Schuurman, KCE Sigaloff… - The Lancet infectious …, 2012 - thelancet.com
Background The effect of pretreatment HIV-1 drug resistance on the response to first-line
combination antiretroviral therapy (ART) in sub-Saharan Africa has not been assessed. We …
combination antiretroviral therapy (ART) in sub-Saharan Africa has not been assessed. We …
Unnecessary antiretroviral treatment switches and accumulation of HIV resistance mutations; two arguments for viral load monitoring in Africa
KCE Sigaloff, RL Hamers, CL Wallis… - JAIDS Journal of …, 2011 - journals.lww.com
Objectives: This study aimed to investigate the consequences of using clinicoimmunological
criteria to detect antiretroviral treatment (ART) failure and guide regimen switches in HIV-…
criteria to detect antiretroviral treatment (ART) failure and guide regimen switches in HIV-…
Patterns of HIV-1 drug resistance after first-line antiretroviral therapy (ART) failure in 6 sub-Saharan African countries: implications for second-line ART strategies
RL Hamers, KCE Sigaloff, AM Wensing… - Clinical infectious …, 2012 - academic.oup.com
Background. Human immunodeficiency virus type 1 (HIV-1) drug resistance may limit the
benefits of antiretroviral therapy (ART). This cohort study examined patterns of drug-resistance …
benefits of antiretroviral therapy (ART). This cohort study examined patterns of drug-resistance …